LipidLabs Finalizes Terms to Acquire Telemedicus, Inc. from Texas A&M

Business Wire, May 15, 2007

HOUSTON -- LipidLabs, Inc. [Pink Sheets: LPDL] announced today that it has reached a final agreement to acquire Telemedicus, Inc. and will close the acquisition within thirty days. Telemedicus was formed in partnership with Texas A&M University and The University of Texas Health Science Center at Houston. Telemedicus has developed the DREAMS technology, an advanced on-board communications and data system, for emergency vehicles and portable military installations. LipidLabs will commercialize this exciting new life-saving technology and market it to commercial users nationwide.

The Telemedicus system includes advanced computer-based communications, medical monitoring and global positioning equipment for emergency vehicles. Through high-quality video, doctors in hospital emergency rooms can see and direct the first responders' treatment of the patient in real-time. This technology improves trauma victims' probability of survival, especially in rural areas or battlefields that are beyond the physical reach of medical specialists in trauma centers.

The Telemedicus technology has been tested in field operations since 2003 in Houston and in Liberty County, Texas. Many lives have already been saved using this technology. It can be used to treat trauma casualties anywhere conventional advanced emergency medical treatment is unavailable - in military operations, offshore drilling operations and in rural communities. Trauma victims will be able to receive a doctor's attention within a few minutes of an ambulance arriving at the scene.

"Acquiring Telemedicus will expand our business. By combining our strengths in the marketplace with the great research developments of Texas A&M and the University of Texas we can expect long term revenue growth and strong profits," stated LipidLabs' President Thomas Cloud. "We are excited about this product and plan to get into thousands of ambulances and emergency locations as fast as possible," he concluded. Potential customers include ambulance companies such as Emergency Medical Services (NYSE: EMS), Rural/Metro Corporation (Nasdaq: RURL) and Spartan Motors, Inc. (Nasdaq: SPAR).

About LipidLabs Inc

LipidLabs, Inc. [Pink Sheets: LPDL] is a publicly held technology transfer and commercialization company based in Houston, Texas. Our primary focus is on acquiring technologies developed by major research universities and delivering those technologies to the marketplace.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.